Nahdi Medical Company
4164
Classifica tra le azioni
#4865
Nahdi Medical Company stands as a prominent pharmaceutical retail chain with... Nahdi Medical Company stands as a prominent pharmaceutical retail chain with operations spanning both the Kingdom of Saudi Arabia and the United Arab Emirates. Its extensive product portfolio encompasses a diverse range of pharmaceutical goods, health and wellness items, maternal and infant care essentials, beauty products, and various fast-moving consumer goods. Beyond retail, Nahdi provides a comprehensive suite of omni-health services, including polyclinics, rapid-care clinics, telemedicine platforms, laboratory facilities, and home healthcare programs. The company is also actively involved in the wholesale and retail distribution of cosmetics, medicines, specialized dietary products, healthy food options, and medical equipment. With approximately 1,151 pharmacies under its management, Nahdi Medical Company was established in 1986 and maintains its headquarters in Jeddah, Saudi Arabia. It operates as a subsidiary under the umbrella of both Alnahdi Holding Company Limited and Saudi Economic and Development Company Limited.
Prezzo delle azioni
$23.42
Capitalizzazione di mercato
$3.05B
Variazione (1 giorno)
-0.45%
Variazione (1 anno)
-27.09%
Paese
SA
Scambia Nahdi Medical Company (4164)
Categoria
Healthcare
Utile per Nahdi Medical Company (4164)
Utile nel Jun 2026 TTM: $217.74M
Secondo gli ultimi rapporti finanziari di Nahdi Medical Company, gli utili attuali della società sono $217.74M. Nel 2023, la società ha registrato un utile di $251.81M, un aumento rispetto a agli utili del 2022, che erano di $249.53M. Gli utili mostrati in questa pagina sono quelli prima degli interessi e delle imposte, ovvero EBIT.
Storico degli utili di Nahdi Medical Company dal 2017 al 2026
Utile alla fine di ogni anno
| Anno | Utile | Cambia |
|---|---|---|
| 2026 (TTM) | $217.74M | -1.98% |
| 2024 | $222.14M | -11.78% |
| 2023 | $251.81M | 0.91% |
| 2022 | $249.53M | 9.27% |
| 2021 | $228.35M | -4.23% |
| 2020 | $238.42M | 16.36% |
| 2019 | $204.91M | 20.34% |
| 2018 | $170.27M | -15.09% |
| 2017 | $200.53M | 0.00% |
Utile per aziende simili o concorrenti
| Azienda | Utile | Differenza negli utili | Il paese |
|---|---|---|---|
| $1.35B | 519.94% |
US
|
|
| - | - |
SE
|
|
| - | - |
FR
|
|
| - | - |
IT
|
|
| $26.37M | -87.89% |
US
|
